[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100652425":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":19,"responsibleParty":41,"collaborators":43,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":49,"sex":55,"minAge":56,"maxAge":19,"enrollmentInfo":57,"targetDuration":19,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":70,"overallStatus":85,"whyStopped":19,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":19},{"fullName":5,"class":6},"Manchester University NHS Foundation Trust","OTHER_GOV",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Wearable-Enabled Prehabilitation and Rehabilitation","EXPERIMENTAL","Participants undergoing pancreatic surgery will receive the Greater Manchester Prehab4Cancer programme supported by wearable monitoring, home physiological monitoring, and remote follow-up throughout the perioperative pathway. Outcomes will be compared with a propensity-score-matched historical cohort identified from routine electronic health records.",[13,14],"Device: Corsano CardioWatch","Behavioral: Prehab4Cancer Programme",{"label":16,"type":17,"description":18,"interventionNames":19},"Matched Historical Standard Care Cohort","NO_INTERVENTION","Historical patients who underwent pancreatic surgery and received standard perioperative care without wearable monitoring. Participants will be identified retrospectively from electronic health records and matched to intervention participants using propensity score methods based on demographic and clinical characteristics. No study intervention will be delivered.",null,[21,26],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":19},"DEVICE","Corsano CardioWatch","A wearable monitoring device used throughout the perioperative pathway to collect continuous physiological and activity data, including measures such as physical activity, heart rate, respiratory rate, oxygen saturation, skin temperature, and sleep-related metrics.",[9],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":19},"BEHAVIORAL","Prehab4Cancer Programme","A personalised prehabilitation and rehabilitation programme comprising exercise, nutritional support, and wellbeing support delivered before and after pancreatic surgery.",[9],[32],{"name":33,"affiliation":5,"role":34},"Lukas Hughes-Noehrer, PhD","PRINCIPAL_INVESTIGATOR",[36],{"name":37,"role":38,"phone":39,"phoneExt":19,"email":40},"Lynne Webster","CONTACT","00441612764125","lynne.webster@mft.nhs.uk",{"type":42,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR",[44],{"name":45,"class":46},"Medtronic","INDUSTRY","100652425","wearable-supported-prehabilitation-and-rehabilitation-for-patients-undergoing-surgery-for-pancreatic-cancer-100652425",false,"NCT07772258","Wearable-Supported Prehabilitation and Rehabilitation for Patients Undergoing Surgery for Pancreatic Cancer","Perioperative Optimisation and Wearable Remote Monitoring of Pancreatic Cancer","POWR-PaC","Inclusion Criteria:\n\n* Adult patients aged 18 years or older.\n* Able to provide informed consent.\n* Able to use the study devices independently or with support from a carer.\n* Approved for pancreatic cancer surgery, including patients undergoing surgery for:\n\nPancreatic cancer Distal cholangiocarcinoma Ampullary carcinoma Duodenal carcinoma Premalignant pancreatic lesions, including Intraductal Papillary Mucinous Neoplasms (IPMNs).\n\n* Clinically stable and considered suitable to participate in the prehabilitation and rehabilitation programme.\n* Owns a smartphone or tablet device\n\nExclusion Criteria:\n\n* Unable or unwilling to provide informed consent.\n* Lacks capacity to provide informed consent.\n* Unstable angina pectoris.\n* Recent myocardial infarction.\n* Recent cerebrovascular accident (stroke).\n* New cardiac arrhythmia.\n* Social, physical, mental health, or substance misuse issues that, in the opinion of the investigator, would jeopardise adherence to study procedures or study contact.\n* No infrastructure for remote monitoring (no access to either mobile signal or Wi-Fi).\n* Clinically unstable or likely to require hospital admission within the next 72 hours.\n* Unable to use the study devices and no carer or support person is available to assist.","ALL","18 Years",{"count":58,"type":59},120,"ESTIMATED","INTERVENTIONAL",[62],"NA","The goal of this clinical trial is to evaluate whether a wearable-enabled prehabilitation and rehabilitation pathway can improve recovery and post-operative outcomes in adults undergoing surgery for pancreatic cancer or related pancreatic\u002Fperiampullary conditions.\n\nThe main questions it aims to answer are:\n\nDoes a wearable-enabled prehabilitation and rehabilitation programme reduce post-operative complications within 30 and 90 days after surgery? Is the use of wearable devices and remote monitoring feasible, acceptable, and useful for patients and healthcare professionals during the perioperative pathway?\n\nResearchers will compare patients receiving the wearable-enabled pathway with a matched historical control group who received standard care to determine whether the intervention is associated with improved surgical and recovery outcomes.\n\nParticipants will:\n\nProvide informed consent and complete baseline assessments and questionnaires. Take part in the Greater Manchester Prehab4Cancer programme before surgery, including personalised exercise, nutritional support, and wellbeing support.\n\nWear a Corsano CardioWatch device to continuously monitor physiological and activity data.\n\nUse home monitoring equipment, including weight scales and blood pressure monitoring devices.\n\nComplete questionnaires and participant logs during prehabilitation and recovery.\n\nReceive regular support from the research team during participation. Undergo pancreatic surgery and receive standard NHS perioperative care. Continue wearable monitoring and rehabilitation after hospital discharge. Be followed for up to 12 months after surgery using routine clinical data to assess recovery, complications, hospital utilisation, and survival.\n\nOptionally participate in a focus group to discuss their experiences of wearable-enabled care.",[65,66,67,68,69],"Pancreatic Cancer","Pancreatic Neoplasms","Periampullary Carcinoma","Pancreatic Surgery","Perioperative Care",[65,68,69,71,72,73,74,75,76,77,78,79,80,81,82,83,84],"Rehabilitation","Prehabilitation","Exercise","Nutrition","Wearables","Remote Monitoring","Digital Health","Mobile Health","Recovery of Function","Patient Monitoring","Telemedicine","Surgical Oncology","PROMS","Electronic Devices","NOT_YET_RECRUITING","2026-08-13",{"date":88,"type":89},"2026-08-19","ACTUAL",{"date":91,"type":59},"2026-10-01",{"date":93,"type":59},"2028-09-30",{"name":5,"class":6}]